Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria R Farcet

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Medical Virology|December 25, 2010
Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulinChristina B Planitzer, Maria R Farcet, Richard I Schiff, et al.
Vaccine|May 8, 2019
Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United StatesMaria R Farcet, Michael Karbiener, Philip O Rabel, et al.
NPJ Vaccines|February 19, 2022
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccinesMichael Karbiener, Maria R Farcet, Andreas Zollner, et al.
Transfusion|September 26, 2020
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donationsChristof Jungbauer, Lukas Weseslindtner, Lisa Weidner, et al.
Biotechnology and Bioengineering|October 19, 2023
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testingMaria R Farcet, Jens Modrof, Gerhard Antoine, et al.
Vaccine|February 25, 2014
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccineCornelia Lackner, Sandra M Leydold, Jens Modrof, et al.
The Journal of Infectious Diseases|September 20, 2021
Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma DonationsMichael Karbiener, Maria R Farcet, Julia Schwaiger, et al.
Transfusion|September 25, 2015
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processesMaria R Farcet, Cornelia Lackner, Gerhard Antoine, et al.
Transfusion|December 12, 2018
Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulinsMaria R Farcet, Jens Modrof, Philip O Rabel, et al.
Journal of Virology|December 3, 2010
Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virusYvonne Hofmeister, Christina B Planitzer, Maria R Farcet, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medical Virology|December 25, 2010
Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulinChristina B Planitzer, Maria R Farcet, Richard I Schiff, et al.
Vaccine|May 8, 2019
Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United StatesMaria R Farcet, Michael Karbiener, Philip O Rabel, et al.
NPJ Vaccines|February 19, 2022
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccinesMichael Karbiener, Maria R Farcet, Andreas Zollner, et al.
Transfusion|September 26, 2020
Characterization of 100 sequential SARS-CoV-2 convalescent plasma donationsChristof Jungbauer, Lukas Weseslindtner, Lisa Weidner, et al.
Biotechnology and Bioengineering|October 19, 2023
Detection of Minute virus of mice strains in different cell lines: Implications for adventitious agent testingMaria R Farcet, Jens Modrof, Gerhard Antoine, et al.
Vaccine|February 25, 2014
Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccineCornelia Lackner, Sandra M Leydold, Jens Modrof, et al.
The Journal of Infectious Diseases|September 20, 2021
Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma DonationsMichael Karbiener, Maria R Farcet, Julia Schwaiger, et al.
Transfusion|September 25, 2015
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processesMaria R Farcet, Cornelia Lackner, Gerhard Antoine, et al.
Transfusion|December 12, 2018
Continued use of poliovirus after eradication: hyper-attenuated strains as a safe alternative for release testing of human immunoglobulinsMaria R Farcet, Jens Modrof, Philip O Rabel, et al.
Journal of Virology|December 3, 2010
Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virusYvonne Hofmeister, Christina B Planitzer, Maria R Farcet, et al.
Pageof 4